Predicting colorectal adenomatous polyps in patients with chronic liver disease: A novel nomogram

doi:10.3748/wjg.v31.i2.99082

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 31, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1512)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-4) series.

Item

Count

PDF

HTML

733

Figures (1-5)

106

Tables (1-4)

Sum=974

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

243

Sum=333

Publishing Process of This Article

Item

Count

Browse

Download

107

Sum=142

Jan 14, 2025 (publication date) through Mar 10, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Jan 14, 2025; 31(2): 99082
Published online Jan 14, 2025. doi: 10.3748/wjg.v31.i2.99082

Table 1 Clinical and laboratory data of patients with chronic liver disease

Variables	Non-polyp (n = 347)	Colorectal polyp (n = 523)		F/H/χ²	P value
Variables	Non-polyp (n = 347)	Adenomatous (n = 249)	Non-adenomatous (n = 274)	F/H/χ²	P value
Male, n (%)	160 (46.1)^a	164 (65.9)	162 (59.1)	24.67	< 0.001
Age (year), mean ± SD	50.8 ± 11.3^a	56.08 ± 10.0	53.6 ± 9.6^a	18.662	< 0.001
BMI (kg/m²), mean ± SD	25.05 ± 3.92^a	26.50 ± 3.80	25.39 ± 3.72^a	10.846	< 0.001
Alcohol, n (%)	71 (20.5)^a	108 (43.4)	67 (24.5)^a	40.41	< 0.001
Smoking, n (%)	88 (25.4)^a	105 (42.2)	81 (29.6)^a	19.676	< 0.001
Diabetes, n (%)	79 (23.0)	74 (29.7)	72 (26.4)	3.4	0.183
Hypertension, n (%)	80 (23.1)^a	74 (29.7)	73 (26.6)^a	8.632	0.013
MS, n (%)	45 (13.0)^a	51 (20.5)	61 (22.3)	10.343	0.006
Cirrhosis, n (%)	172 (49.6)	126 (46.0)	113 (45.4)	1.272	0.529
FPG (mmol/L), mean ± SD	5.9 ± 1.6^a	6.4 ± 2.5	6.1 ± 1.7	4.017	0.018
HDL (mmol/L), mean ± SD	1.3 ± 0.4^a	1.2 ± 0.3	1.3 ± 0.5^a	4.103	0.017
CHO (mmol/L), median (IQR)	4.56 (3.88, 5.39)	4.51 (3.78, 5.35)	4.51 (3.79, 5.63)	1.056	0.59
TG (mmol/L), mean ± SD	1.3 ± 1.2	1.4 ± 0.6	1.4 ± 1.2	0.579	0.561
LDL (mmol/L), mean ± SD	2.8 ± 0.8	2.9 ± 0.9	2.9 ± 1.0	1.745	0.175
PLT (10⁹/L), median (IQR)	161.00 (103.00, 203.00)	153.00 (93.00, 213.00)	168.50 (112.00, 231.25)	5.841	0.054
TP (g/L), mean ± SD	71.7 ± 7.7	71.3 ± 8.1	70.4 ± 8.4	1.964	1.141
ALB (g/L), mean ± SD	41.4 ± 5.8	39.9 ± 6.5	40.2 ± 6.0	4.148	0.016
SI (μmol/L), mean ± SD	20.8 ± 9.4^a	23.6 ± 11.7	24.5 ± 13.6^a	11.607	< 0.001
SF (μg/L), median (IQR)	125.00 (60.00, 247.00)^a	215.00 (101.00, 356.50)	174.00 (79.75, 363.50)^a	29.928	< 0.001
TRF (g/L), median (IQR)	2.55 (2.22, 3.17)	2.57 (2.20, 3.17)	2.56 (2.31, 3.22)	0.3	0.985
TSH (mIU/L), mean ± SD	2.6 ± 3.5^a	2.1 ± 1.3	2.2 ± 1.7^a	4.5	0.011
FT4 (pmol/L), mean ± SD	16.7 ± 13.0	17.6 ± 7.0	19.7 ± 9.8	2.829	0.06
FT3 (pmol/L), mean ± SD	4.9 ± 1.3	5.0 ± 0.7	5.1 ± 1.7	0.955	0.382
ALT (IU/L), median (IQR)	30.00 (18.3, 65.3)	37.00 (21.4, 70.10)	34.85 (20.55, 72.60)	1.087	0.336
AST (IU/L), median (IQR)	31.80 (21.70, 62.20)	36.70 (23.30, 68.77)	34.85 (22.00, 70.62)	3.411	0.182
GGT (IU/L), median (IQR)	52.90 (23.00, 96.50)^a	57.60 (28.60, 142.00)	59.00 (25.97, 189.07)	7.632	0.022

^aP < 0.05 vs adenomatous polyp.

BMI: Body mass index; MS: Metabolic syndrome; FPG: Fasting plasma glucose; HDL: High-density lipoprotein; CHO: Cholesterol; TG: Triacylglycerol; LDL: Low-density lipoprotein; PLT: Platelet count; TP: Total protein; ALB: Albumin; SI: Serum iron; SF: Serum ferritin; TRF: Transferrin; TSH: Thyroid-stimulating hormone; FT3: Free T3; FT4: Free T4; ALT: Alanine aminotransferase; AST: Aspartate transaminase; GGT: Gamma-glutamyl transferase; IQR: Interquartile range.

Citation: Li YQ, Kuai WT, Chen L, Zeng MH, Tao XM, Han JX, Wang YK, Xu LX, Ge LY, Liu YG, Li S, Xu L, Mi YQ. Predicting colorectal adenomatous polyps in patients with chronic liver disease: A novel nomogram. World J Gastroenterol 2025; 31(2): 99082
URL: https://www.wjgnet.com/1007-9327/full/v31/i2/99082.htm
DOI: https://dx.doi.org/10.3748/wjg.v31.i2.99082